The management of the clinical trial in Italy after the Brexit

  On 29 March 2017 The United Kingdom notified its intention to withdraw from the European Union.  Thus, unless there…

READ

Optimising Orphan Drug Development in the EU

  The legislative framework on orphan medicinal products aims at stimulating research and development of medicinal products for rare diseases…

READ

Changes to the procedure for the request of access to the “AIFA 5% fund”

Changes have recently been introduced by AIFA concerning the procedure for the request of access to the so-called “AIFA 5%…

READ

REGISTRATION OF MEDICINES IN THE EURASIAN ECONOMIC UNION

After the Decision No. 78 of the Board Eurasian Economic Commission (EEC) oN November 3rd, 2016, the “Rules” for registration…

READ

AIFA – SALES REPRESENTATIVE DATA TRANSMISSION

We are getting close to the deadline relevant to the annual transmission to AIFA of the sales representative data. Every year,…

READ

AIFA – PRICE INCREASE OF CLASS C MEDICINAL PRODUCTS SUBJECT TO MEDICAL PRESCRIPTION

AIFA has recently circulated on its website the communication about the price increase of Class C medicinal products subject to…

READ

MEDICAL DEVICES – NEW CLASSIFICATION REQUIREMENTS ACCORDING TO EUROPEAN REGULATION 2017/745

The European regulation 2017/745, that will become effective in May 2020, introduces several new requirements with an impact on several…

READ

IMPLEMENTATION OF A NEW VERSION OF THE OsSC PLATFORM FOR THE SUBMISSION OF CTAs AND AMENDMENTS IN ITALY

Changes in the management of Clinical Trial Applications and amendments have recently been introduced in Italy. A new version of…

READ

BREXIT- ARE YOU FULFILLING YOUR TASKS?

Further to the Brexit, all Union laws cease to apply to the United Kingdom from 30th March 2019. The “transition…

READ

AIFA – ANNUAL FEE 2017: UPCOMING DEADLINE FOR PAYMENT (JULY 31ST, 2018)

We are getting close to the deadline relevant to the payment of the annual fee due to AIFA. Every year,…

READ